Combining Oncolytic Virotherapy and Cytotoxic Therapies to Fight Cancer
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6513-6521
Author(s):
Cristina Fillat, Maria Victoria Maliandi, Ana Mato-Berciano and Ramon Alemany
Combined Modality Therapy in Pancreatic Adenocarcinoma: Review and Updates on a Controversial Issue
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6697-6701
Author(s):
Ludimila Cavalcante, David P. Kelsen and Kenneth H. Yu
Smoking and Atherosclerosis: Mechanisms of Disease and New Therapeutic Approaches
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3936-3948
Author(s):
Gerasimos Siasos, Vasiliki Tsigkou, Eleni Kokkou, Evangelos Oikonomou, Manolis Vavuranakis, Charalambos Vlachopoulos, Alexis Verveniotis, Maria Limperi, Vasiliki Genimata, Athanasios G. Papavassiliou, Christodoulos Stefanadis and Dimitris Tousoulis
Conventional Anticancer Therapeutics and Telomere Maintenance Mechanisms
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6452-6465
Author(s):
Orit Uziel and Meir Lahav
Molecular Markers of Angiogenesis and Metastasis in Lines of Oral Carcinoma after Treatment with Melatonin
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
1302-1311
Author(s):
Naiane do Nascimento Goncalves, Rodrigo Ventura Rodrigues, Bruna Victorasso Jardim-Perassi, Marina Gobbe Moschetta, Juliana Ramos Lopes, Jucimara Colombo and Debora Aparecida Pires de Campos Zuccari
Nanoparticulate Drug Delivery Sytem for Cancer Therapy: Oppourtunities and Challenges
Journal:
Recent Patents on Nanomedicine
Volume:
4
Page:
32-45
Author(s):
Priya Patel, Mihir Raval and Navin Sheth
Design, Synthesis and in vitro Cytotoxicity Evaluation of New 3',4'-bis (3,4,5-trisubstituted)-4'H-spiro[indene-2,5'-isoxazol]-1(3H)-one Derivatives as Promising Anticancer Agents
Journal:
Letters in Drug Design & Discovery
Volume:
11
Page:
1149-1161
Author(s):
Hoda Abolhasani, Afshin Zarghi, Ahmad Abolhasani, Maryam Hamzeh-Mivehroud, Nasrin Bargahi, Behrouz Notash, Javid Shahbazi Mojarrad and Siavoush Dastmalchi
Ligand-Based Drug Design of Novel MARK-3 Inhibitors in Cancer
Journal:
Current Bioactive Compounds
Volume:
10
Page:
112-123
Author(s):
Jonathan R. de Almeida, Josiana G. de Araujo Volpini, Joao G.C. Poiani, Carlton A. Taft and Carlos H.T. de Paula da Silva
Structure-Based Drug Design of Novel MARK-3 Inhibitors in Cancer
Journal:
Current Bioactive Compounds
Volume:
10
Page:
131-138
Author(s):
Josiana G. de Araujo Volpini, Ricardo P. Rodrigues, Leonardo B. Federico and Carlos H.T. de Paula da Silva
A Proposed Screening Paradigm for Discovery of Covalent Inhibitor Drugs
Journal:
Drug Metabolism Letters
Volume:
8
Page:
19-30
Author(s):
Mehran F. Moghaddam, Yang Tang, Zhihong O’Brien, Samantha J. Richardson, Maria Bacolod, Prasoon Chaturedi, Julius Apuy and Ashutosh Kulkarni